Press release
Companion Diagnostic Tests in Oncology Market Outlook 2034: Projected to Reach USD 17.0 Billion, Growing at a CAGR of 9.5% | TMR
Companion diagnostic tests play a pivotal role in modern oncology, enabling personalized treatment approaches by identifying patients most likely to benefit from specific therapies. These tests have become indispensable in the era of precision medicine, guiding clinical decisions and improving treatment outcomes. The companion diagnostic tests market in oncology is experiencing robust growth, driven by advancements in molecular diagnostics, increasing prevalence of cancer, and the growing adoption of targeted therapies.The global companion diagnostic tests in oncology market is valued at several billion dollars. Key factors driving this growth include the rising prevalence of cancer, expanding pipeline of targeted therapies, and increasing demand for personalized medicine. North America currently dominates the market, followed by Europe and the Asia-Pacific region, which is emerging as a high-growth area. It is expected to grow at a CAGR of 9.5% from 2024 to 2034 and reach US$ 17.0 Bn by the end of 2034.
Get A Free Sample Copy of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4684
Top Companies:
Abbott
F. Hoffmann-LA Roche AG
Genomic Health, Inc.
QIAGEN
Agilent Technologies, Inc.
AGENDIA N.V.
bioMérieux SA
Illumina, Inc.
Siemens Healthineers
Thermo Fisher Scientific Inc.
BioGenex
Key Drivers
Rise in Cancer Incidence: The increasing global burden of cancer, with millions of new cases diagnosed annually, is driving the demand for effective diagnostic tools.
Advancements in Molecular Diagnostics: Innovations in genomics and next-generation sequencing (NGS) are enhancing the accuracy and scope of companion diagnostics.
Growth in Targeted Therapies: The growing pipeline of targeted cancer therapies, such as immune checkpoint inhibitors and tyrosine kinase inhibitors, relies heavily on companion diagnostics for patient selection.
Regulatory Support: Streamlined approval processes and supportive regulatory frameworks, such as co-approval of drugs and diagnostics, are accelerating market growth.
Increasing Adoption of Precision Medicine: Healthcare systems worldwide are embracing precision medicine, which depends on the integration of companion diagnostics.
Recent Trends
Integration with Artificial Intelligence: AI-driven algorithms are being developed to enhance the predictive power of companion diagnostics and identify new biomarkers.
Focus on Liquid Biopsies: Non-invasive liquid biopsy techniques are gaining traction as a complement or alternative to traditional tissue biopsies.
Collaborations and Partnerships: Increased collaboration between diagnostic companies, pharmaceutical firms, and research institutions is fostering innovation and market expansion.
Expansion into Emerging Markets: Companies are increasingly targeting developing regions to address unmet needs and capitalize on growing healthcare investments.
Broader Application Scope: Companion diagnostics are being expanded beyond traditional applications to include multiple cancer types and combination therapies.
To Know More About Report: https://www.transparencymarketresearch.com/companion-diagnostic-tests-market.html
Market Segmentation
By Detection Technique
Protein Detection
Immunohistochemistry
DNA Detection
Polymerase Chain Reaction (PCR)
Next-generation Sequencing (NGS)
In Situ Hybridization
Others
By Biomarker
EGFR
KRAS
HER2
BRAF V600E
Others
By Cancer Type
Breast Cancer
Lung Cancer
Colorectal Cancer
Liver Cancer
Melanoma
Others
By End-user
Hospitals
Specialty Clinics
Diagnostic Labs
Others
Regions
North America
Europe
Asia Pacific
Middle East & Africa
South America
Conclusion
The companion diagnostic tests in oncology market is poised for substantial growth, driven by the increasing adoption of personalized medicine and advancements in molecular diagnostics. Addressing challenges such as high costs and regulatory complexities will be essential for broader market penetration. Collaborative efforts between stakeholders, including pharmaceutical companies, diagnostic firms, and regulatory bodies, will play a crucial role in shaping the future of this market.
Visit our report to discover essential insights and analysis - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4684
Atopic Dermatitis Drugs Market: https://www.globenewswire.com/news-release/2023/07/31/2715115/32656/en/Atopic-Dermatitis-Drugs-Market-to-Grow-at-a-CAGR-of-14-7-from-2022-to-2031-reaching-USD-29-4-Billion-As-per-TMR-Study.html
Oligonucleotides Market: https://www.globenewswire.com/news-release/2024/12/02/2989923/32656/en/Oligonucleotides-Market-Outlook-2034-Projected-to-Reach-US-13-1-Billion-by-2034-Driven-by-Expanding-Applications-in-Biotechnology-and-Precision-Medicine-TMR.html
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact Us:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Companion Diagnostic Tests in Oncology Market Outlook 2034: Projected to Reach USD 17.0 Billion, Growing at a CAGR of 9.5% | TMR here
News-ID: 3784245 • Views: …
More Releases from Transparency Market Research
Animal Genetics Market Outlook 2034: Projected Growth at a CAGR of 5.4%
The global animal genetics market is witnessing substantial growth, fueled by advancements in genetic technologies and an increasing demand for animal-derived products. This industry plays a pivotal role in improving livestock and companion animal breeds, contributing to enhanced productivity, disease resistance, and sustainability.
The report provides a comprehensive overview of the market, offering insights into its growth drivers, key segments, regional dynamics, competitive landscape, and future outlook.
Examine key highlights and takeaways…
3D Bioprinting Market Trends and Forecasts: How the Industry Will Reach USD 5.7 …
The global 3D bioprinting market is rapidly advancing, driven by the growing need for more effective methods of organ transplantation, tissue regeneration, and drug testing. The technology, which combines bioinks and living cells to create tissue-like structures, is revolutionizing various industries, particularly in healthcare and cosmetics.
According to recent market reports, the 3D bioprinting market, valued at USD 1.6 billion in 2023, is projected to expand at a compound annual growth…
AI in Oncology Market Outlook 2034: Projected to Reach USD 7.7 Billion at a CAGR …
Artificial intelligence (AI) is reshaping the healthcare industry, with oncology being one of its most impactful applications. The AI in oncology market is experiencing rapid growth due to its ability to analyze vast datasets, facilitate accurate diagnoses, predict disease progression, and recommend personalized treatment options.
These capabilities are transforming cancer care, empowering oncologists with tools to improve patient outcomes. In 2023, the global AI in oncology market was valued at USD…
Acrylic Teeth Market Outlook 2034: Poised to Reach USD 1.1 Billion with a CAGR o …
The acrylic teeth market is poised for remarkable growth over the next decade, driven by increasing incidences of dental caries, periodontal diseases, and the rising demand for cosmetic dentistry.
Acrylic teeth, made from durable, moldable plastic-like materials, are becoming the preferred choice for partial and complete dentures due to their affordability, flexibility, and natural appearance.
Discover valuable insights and findings from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86011
The global market for acrylic…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
Oncology Nutrition Market led to an unprecedented rise by 2025 : liver cancer, p …
Global Oncology Nutrition Market: Overview
Cancer diagnosis creates myriad questions about diet and nutrition. Those pertain to if the food will make a patient feel sick to what should be ingested to fight cancer. This has spawned the oncology nutrition market which has been rising steadily due to the increasing cases of different types of cancer worldwide. During cancer treatment one needs to eat right in order to build up strength…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports.
This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.
This report focuses on top…
